The Global Biosimilars Market is projected to reach USD 44.7 billion by 2026 from USD 15.6 billion in 2021, at a CAGR of 23.5% during the forecast period of 2021 to 2026.
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |